We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BN icon
351
Brookfield
BN
$102B
$3.01M 0.06%
232,131
+48,524
+26% +$615K
CAG icon
352
Conagra Brands
CAG
$7.07B
$3M 0.06%
74,416
+2,356
+3% +$94K
GHDX
353
DELISTED
Genomic Health, Inc.
GHDX
$2.99M 0.06%
95,000
+8,000
+9% +$237K
DTE icon
354
DTE Energy
DTE
$31.1B
$2.97M 0.06%
34,148
+6,256
+22% +$530K
CSX icon
355
CSX Corp
CSX
$98.6B
$2.97M 0.06%
191,157
-20,604
-10% -$314K
CEVA icon
356
CEVA Inc
CEVA
$1.01B
$2.95M 0.06%
83,046
+41,928
+102% +$1.45M
PXD
357
DELISTED
Pioneer Natural Resource Co.
PXD
$2.94M 0.06%
15,769
+3,160
+25% +$586K
RRC icon
358
Range Resources
RRC
$9.11B
$2.92M 0.06%
100,315
+28,669
+40% +$885K
GBT
359
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.84M 0.05%
77,000
– –
HALO icon
360
Halozyme
HALO
$9.72B
$2.81M 0.05%
217,000
-123,000
-36% -$1.55M
MNTA
361
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.8M 0.05%
210,000
+140,000
+200% +$2.19M
CME icon
362
CME Group
CME
$92.2B
$2.79M 0.05%
23,518
+5,029
+27% +$605K
M icon
363
Macy's
M
$6.15B
$2.77M 0.05%
93,552
-4,683
-5% -$145K
LEG icon
364
Leggett & Platt
LEG
$1.52B
$2.77M 0.05%
55,086
-1,577
-3% -$77K
S
365
DELISTED
Sprint Corporation
S
$2.74M 0.05%
315,856
+97,068
+44% +$848K
PCRX icon
366
Pacira BioSciences
PCRX
$1.02B
$2.74M 0.05%
+60,000
New +$2.59M
CST
367
DELISTED
CST Brands, Inc.
CST
$2.73M 0.05%
56,880
– –
LPL icon
368
LG Display
LPL
$3.17B
$2.72M 0.05%
+200,000
New +$2.58M
SWN
369
DELISTED
Southwestern Energy Company
SWN
$2.72M 0.05%
333,050
+118,473
+55% +$1.03M
BRCD
370
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$2.72M 0.05%
217,926
– –
ECL icon
371
Ecolab
ECL
$75.6B
$2.68M 0.05%
21,357
-9,608
-31% -$1.17M
ANET icon
372
Arista Networks
ANET
$219B
$2.65M 0.05%
320,896
+102,576
+47% +$708K
MACK
373
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.65M 0.05%
109,179
+76,896
+238% +$1.92M
ZGNX
374
DELISTED
Zogenix, Inc.
ZGNX
$2.64M 0.05%
243,000
+93,000
+62% +$942K
SYY icon
375
Sysco
SYY
$39.7B
$2.63M 0.05%
50,623
+10,320
+26% +$547K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.